Iran's health Minister has announced that the country is planning to begin mass production and marketing of 12 new biotech medications, Press TV reported.
Dr. Marzieh Vahid-Dastjerdi said plans are in the making for the production of 12 high-tech medication with potential market release date of early February, coinciding with the 10 days of dawn events celebrating the anniversary of the Islamic Revolution.
The new products include anti-cancer medicines, an infertility drug, and other medications used in asthma, Multiple sclerosis (MS), and other disabling ailments, she added.
Currently, according to Dastjerdi, the new products are undergoing clinical trials to gain approval by health ministry's Food and Drug Administration prior to their placement on the national market.
She went on to say that at least three to four of the products would be marketed by February and the rest are scheduled to become available early in the next Iranian calendar year that begins on March 21.
The health minister estimated that the mass production of the new high-tech medications may save about $250 million for Iran.
According to the heath minister, Iran has already marketed nine biotech drugs and with addition of the new 12 medications as well as 10 more planned for later releases, the overall number of biotech medicines produced in the country will reach 30 within the next three years.
She added that in terms of producing medications through nanotechnology, Iran is ranked first in the Middle East and fifth in all of Asia with plans to lead the continent in a near future.